Tril targets Smad7 for degradation to allow hematopoietic specification in Xenopus embryos

Development. 2016 Nov 1;143(21):4016-4026. doi: 10.1242/dev.141812. Epub 2016 Sep 15.

Abstract

In Xenopus laevis, bone morphogenetic proteins (Bmps) induce expression of the transcription factor Gata2 during gastrulation, and Gata2 is required in both ectodermal and mesodermal cells to enable mesoderm to commit to a hematopoietic fate. Here, we identify tril as a Gata2 target gene that is required in both ectoderm and mesoderm for primitive hematopoiesis to occur. Tril is a transmembrane protein that functions as a co-receptor for Toll-like receptors to mediate innate immune responses in the adult brain, but developmental roles for this molecule have not been identified. We show that Tril function is required both upstream and downstream of Bmp receptor-mediated Smad1 phosphorylation for induction of Bmp target genes. Mechanistically, Tril triggers degradation of the Bmp inhibitor Smad7. Tril-dependent downregulation of Smad7 relieves repression of endogenous Bmp signaling during gastrulation and this enables mesodermal progenitors to commit to a blood fate. Thus, Tril is a novel component of a Bmp-Gata2 positive-feedback loop that plays an essential role in hematopoietic specification.

Keywords: Bmp; Gata2; Primitive hematopoiesis; Smad7; Tril.

MeSH terms

  • Animals
  • Cell Differentiation
  • Embryo, Nonmammalian
  • Embryonic Development / physiology
  • Gene Expression Regulation, Developmental
  • Hematopoiesis* / genetics
  • Intracellular Signaling Peptides and Proteins / physiology*
  • Membrane Proteins
  • Proteolysis*
  • Smad7 Protein / metabolism*
  • Xenopus Proteins / physiology*
  • Xenopus laevis / embryology*
  • Xenopus laevis / genetics
  • Xenopus laevis / metabolism

Substances

  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Smad7 Protein
  • Tril protein, Xenopus
  • Xenopus Proteins